UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 982

Sortiert nach

Targeted anti-mitotic therapies: can we improve on tubulin agents?

Nature reviews. Cancer, 2007-02, Vol.7 (2), p.107-117

2007

Volltextzugriff (PDF)

Distinct Concentration-Dependent Effects of the Polo-like Kinase 1―Specific Inhibitor GSK461364A, Including Differential Effect on Apoptosis

Cancer research (Chicago, Ill.), 2009-09, Vol.69 (17), p.6969-6977

2009

Volltextzugriff (PDF)

Building successful leadership coaching relationships: Examining impact of matching criteria in a leadership coaching program

The Journal of management development, 2010-01, Vol.29 (10), p.914-931

2010

Volltextzugriff (PDF)

Centromere-Associated Protein E: A Motor That Puts the Brakes on the Mitotic Checkpoint

Clinical cancer research, 2008-12, Vol.14 (23), p.7588-7592

2008

Volltextzugriff (PDF)

An immune-active tumor microenvironment favors clinical response to ipilimumab

Cancer Immunology, Immunotherapy, 2012-07, Vol.61 (7), p.1019-1031

2012

Volltextzugriff (PDF)

The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophore

The Journal of pharmacology and experimental therapeutics, 2002-11, Vol.303 (2), p.858

2002

Volltextzugriff (PDF)

Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab

Cancer Immunology, Immunotherapy, 2012-05, Vol.61 (5), p.733-737

2012

Volltextzugriff (PDF)

Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295

ACS medicinal chemistry letters, 2010-04, Vol.1 (1), p.30-34

2010

Volltextzugriff (PDF)

Antitumor activity of an allosteric inhibitor of centromere-associated protein-E

Proceedings of the National Academy of Sciences - PNAS, 2010-03, Vol.107 (13), p.5839-5844

2010

Volltextzugriff (PDF)

Lessons for Experience: Why Wait?

Industrial and organizational psychology, 2010-03, Vol.3 (1), p.48-51

2010

Volltextzugriff (PDF)

Constitutive expression of angiopoietin-1 and -2 and modulation of their expression by inflammatory cytokines in rheumatoid arthritis synovial fibroblasts

Journal of rheumatology, 2002-02, Vol.29 (2), p.230

2002

Volltextzugriff (PDF)

Past and future of the mitotic spindle as an oncology target

Current Opinion in Pharmacology, 2001-08, Vol.1 (4), p.370-377

2001

Volltextzugriff (PDF)

Novel ATP-Competitive Kinesin Spindle Protein Inhibitors

Journal of medicinal chemistry, 2007-10, Vol.50 (20), p.4939-4952

2007

Volltextzugriff (PDF)

ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism

Nature chemical biology, 2007-11, Vol.3 (11), p.722-726

2007

Volltextzugriff (PDF)

Integrated analysis of breast cancer cell lines reveals unique signaling pathways

Genome biology, 2009-03, Vol.10 (3), p.R31-R31

2009

Volltextzugriff (PDF)

An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage

Cancer research (Chicago, Ill.), 2000-02, Vol.60 (3), p.566-572

2000

Volltextzugriff (PDF)

Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding

Bioorganic & medicinal chemistry letters, 2009-03, Vol.19 (6), p.1694-1697

2009

Volltextzugriff (PDF)

Mechanism of Inhibition of Human KSP by Monastrol: Insights from Kinetic Analysis and the Effect of Ionic Strength on KSP Inhibition

Biochemistry (Easton), 2004-12, Vol.43 (48), p.15258-15266

2004

Volltextzugriff (PDF)

Identification of Drosophila Myt1 kinase and its role in Golgi during mitosis

Cellular signalling, 2002-05, Vol.14 (5), p.467-476

2002

Volltextzugriff (PDF)

G2 Checkpoint Control: Checking in to the Last Resort for DNA Damage

Cancer biology & therapy, 2004-03, Vol.3 (3), p.314-316

2004

Volltextzugriff (PDF)

Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: Potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties

Bioorganic & medicinal chemistry letters, 2010-08, Vol.20 (15), p.4587-4592

2010

Volltextzugriff (PDF)

Conformation-Dependent Ligand Regulation of ATP Hydrolysis by Human KSP: Activation of Basal Hydrolysis and Inhibition of Microtubule-Stimulated Hydrolysis by a Single, Small Molecule Modulator

Journal of the American Chemical Society, 2008-06, Vol.130 (24), p.7584-7591

2008

Volltextzugriff (PDF)

Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models

The Journal of pharmacology and experimental therapeutics, 1998-02, Vol.284 (2), p.687

1998

Volltextzugriff (PDF)

The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis

Biochimica et biophysica acta, 1998-05, Vol.1392 (1), p.145-152

1998

Volltextzugriff (PDF)

1 – 25 von 982

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(879)
Mit Volltextzugriff
(798)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Targeted anti-mitotic therapies: can we improve on tubulin agents?

Distinct Concentration-Dependent Effects of the Polo-like Kinase 1―Specific Inhibitor GSK461364A, Including Differential Effect on Apoptosis

Building successful leadership coaching relationships: Examining impact of matching criteria in a leadership coaching program

Centromere-Associated Protein E: A Motor That Puts the Brakes on the Mitotic Checkpoint

An immune-active tumor microenvironment favors clinical response to ipilimumab

The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophore

Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab

Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295

Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin

Antitumor activity of an allosteric inhibitor of centromere-associated protein-E

Lessons for Experience: Why Wait?

Constitutive expression of angiopoietin-1 and -2 and modulation of their expression by inflammatory cytokines in rheumatoid arthritis synovial fibroblasts

Past and future of the mitotic spindle as an oncology target

Novel ATP-Competitive Kinesin Spindle Protein Inhibitors

ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism

Integrated analysis of breast cancer cell lines reveals unique signaling pathways

An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage

Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding

Mechanism of Inhibition of Human KSP by Monastrol: Insights from Kinetic Analysis and the Effect of Ionic Strength on KSP Inhibition

Identification of Drosophila Myt1 kinase and its role in Golgi during mitosis

G2 Checkpoint Control: Checking in to the Last Resort for DNA Damage

Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: Potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties

Conformation-Dependent Ligand Regulation of ATP Hydrolysis by Human KSP: Activation of Basal Hydrolysis and Inhibition of Microtubule-Stimulated Hydrolysis by a Single, Small Molecule Modulator

Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models

The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis

Suchergebnisse filtern